Nexeon MedSystems Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NXNN research report →
Price Chart
About the company
Nexeon MedSystems Inc. operates as a medical device enterprise, dedicated to the innovation, production, and market launch of neurostimulation solutions. These solutions leverage electrical impulses to modulate neural activity, offering therapeutic interventions for a spectrum of neurological conditions.
- CEO
- William Rosellini
- IPO
- 2017
- Employees
- 62
- HQ
- Dallas, TX, US
Get TickerSpark's AI analysis on NXNN
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $78.63K
- P/E
- -0.00
- PEG
- -0.00
- P/S
- 0.02
- P/B
- 0.00
- EV/EBITDA
- -4.45
- Div Yield
- 0.00%
- Gross Margin
- -9.59%
- Op Margin
- -189.69%
- Net Margin
- -65.93%
- ROE
- -18.78%
- ROIC
- -38.91%
Latest fiscal year · YoY change
- Revenue
- $3.30M+120.9%
- Gross Profit
- $-316,691-138.7%
- Op Income
- $-6,264,990
- Net Income
- $-2,177,641-171.4%
- EPS
- $-1.23-108.5%
- OCF Growth
- -1181.6%
- FCF Growth
- -1343.8%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 486.97
- RSI (14)
- 0
- Avg Volume
- 0
No earnings-call transcripts are available for NXNN yet.
- Free Float
- 0.1%
- Shares Outstanding
- 786.25M
- Float Shares
- 1.00M
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jan 8, 19 | Rosellini William | other | 26,500 |
| Jan 8, 19 | Rosellini William | other | 19,000 |
| Jan 8, 19 | Rosellini William | other | 35,000 |
| Jan 8, 19 | Rosellini William | other | 402,785 |
| Nov 14, 18 | Rosellini William | other | 70,000 |
| Sep 24, 18 | Rosellini William | other | 367,785 |
| Feb 28, 18 | Rosellini William | other | 900,000 |
| Feb 28, 18 | Rosellini William | other | 250,000 |
| Sep 5, 17 | Rosellini William | other | 475,000 |
| Sep 5, 17 | Rosellini William | other | 156,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our NXNN coverage
Recent articles, reports, and earnings notes.
No research on NXNN yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate NXNN report →QT Imaging (NASDAQ:QTI) vs. Nexeon Medsystems (OTCMKTS:NXNN) Financial Review
defenseworld.net · Mar 12
Head-To-Head Review: QT Imaging (NASDAQ:QTI) and Nexeon Medsystems (OTCMKTS:NXNN)
defenseworld.net · Mar 11
QT Imaging (NASDAQ:QTI) and Nexeon Medsystems (OTCMKTS:NXNN) Critical Survey
defenseworld.net · Mar 9
Critical Comparison: QT Imaging (NASDAQ:QTI) vs. Nexeon Medsystems (OTCMKTS:NXNN)
defenseworld.net · Feb 20
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.